glp-1 landscape The Medicine Maker The evolving landscape of anti-obesity
Description
The studys authors examined over 3,000 participants, none of whom had diabetes or were taking medication to lower their blood sugar
[8] Making Careful Food Choices At the beginning of your treatment, doctors suggest focusing on simple, easy-to-digest foods with adequate protein and fiber
doi: 10.3390/ijms25084300
1 The arrival of glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications originally developed for type 2 diabetes, has reshaped the treatment landscape
The study period on medication or placebo following the lifestyle intervention is 72 weeks (84)
